Literature DB >> 30723938

Translational Metabolism: A multidisciplinary approach towards precision diagnosis of inborn errors of metabolism in the omics era.

Ronald J A Wanders1,2, Frederic M Vaz1,2, Sacha Ferdinandusse1,2, André B P van Kuilenburg1,2, Stephan Kemp1,2, Clara D van Karnebeek1,2, Hans R Waterham1,2, Riekelt H Houtkooper1,2.   

Abstract

The laboratory diagnosis of inborn errors of metabolism has been revolutionized in recent years, thanks to the amazing developments in the field of DNA sequencing including whole exome and whole genome sequencing (WES and WGS). Interpretation of the results coming from WES and/or WGS analysis is definitely not trivial especially since the biological relevance of many of the variants identified by WES and/or WGS, have not been tested experimentally and prediction programs like POLYPHEN-2 and SIFT are far from perfect. Correct interpretation of WES and/or WGS results can only be achieved by performing functional studies at multiple levels (different metabolomics platforms, enzymology, in vitro and in vivo flux analysis), often requires studies in model organisms like zebra fish, Caenorhabditis elegans, Saccharomyces cerevisiae, mutant mice and others, and also requires the input of many different disciplines to make this Translational Metabolism approach effective.
© 2018 SSIEM.

Entities:  

Keywords:  fatty acids; inborn errors of metabolism; metabolism; mitochondria; peroxisomes

Mesh:

Year:  2019        PMID: 30723938     DOI: 10.1002/jimd.12008

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  8 in total

Review 1.  Understanding Inborn Errors of Metabolism through Metabolomics.

Authors:  Karen Driesen; Peter Witters
Journal:  Metabolites       Date:  2022-04-27

Review 2.  Treatable inherited metabolic disorders causing intellectual disability: 2021 review and digital app.

Authors:  Eva M M Hoytema van Konijnenburg; Saskia B Wortmann; Marina J Koelewijn; Laura A Tseng; Roderick Houben; Sylvia Stöckler-Ipsiroglu; Carlos R Ferreira; Clara D M van Karnebeek
Journal:  Orphanet J Rare Dis       Date:  2021-04-12       Impact factor: 4.123

Review 3.  How to proceed after "negative" exome: A review on genetic diagnostics, limitations, challenges, and emerging new multiomics techniques.

Authors:  Saskia B Wortmann; Machteld M Oud; Mariëlle Alders; Karlien L M Coene; Saskia N van der Crabben; René G Feichtinger; Alejandro Garanto; Alex Hoischen; Mirjam Langeveld; Dirk Lefeber; Johannes A Mayr; Charlotte W Ockeloen; Holger Prokisch; Richard Rodenburg; Hans R Waterham; Ron A Wevers; Bart P C van de Warrenburg; Michel A A P Willemsen; Nicole I Wolf; Lisenka E L M Vissers; Clara D M van Karnebeek
Journal:  J Inherit Metab Dis       Date:  2022-05-22       Impact factor: 4.750

Review 4.  Genetics of mitochondrial diseases: Identifying mutations to help diagnosis.

Authors:  Sarah L Stenton; Holger Prokisch
Journal:  EBioMedicine       Date:  2020-05-23       Impact factor: 11.205

Review 5.  A Great Catch for Investigating Inborn Errors of Metabolism-Insights Obtained from Zebrafish.

Authors:  Maximilian Breuer; Shunmoogum A Patten
Journal:  Biomolecules       Date:  2020-09-22

Review 6.  2022 Overview of Metabolic Epilepsies.

Authors:  Birute Tumiene; Carlos R Ferreira; Clara D M van Karnebeek
Journal:  Genes (Basel)       Date:  2022-03-12       Impact factor: 4.096

7.  Personalized medicine for rare neurogenetic disorders: can we make it happen?

Authors:  Agnies M van Eeghen; Hilgo Bruining; Nicole I Wolf; Arthur A Bergen; Riekelt H Houtkooper; Mieke M van Haelst; Clara D van Karnebeek
Journal:  Cold Spring Harb Mol Case Stud       Date:  2022-03-24

8.  An improved functional assay in blood spot to diagnose Barth syndrome using the monolysocardiolipin/cardiolipin ratio.

Authors:  Frédéric M Vaz; Henk van Lenthe; Martin A T Vervaart; Femke S Stet; Johanne H Klinkspoor; Hilary J Vernon; Susan M I Goorden; Riekelt H Houtkooper; Willem Kulik; Ronald J A Wanders
Journal:  J Inherit Metab Dis       Date:  2021-08-24       Impact factor: 4.750

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.